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Editorial
Adipocytokines and The Expanding ‘Asian Indian
Phenotype’
V Mohan, R Deepa
expenditure.13 In addition to adipocytokines, pro-
inflammatory markers like tumour necrosis factor-α
[TNF- α] inhibit insulin signaling in human adipocytes,14
enhance insulin resistance and increase the risk for
diabetes. Recent reports show that Indians have low
levels of adiponectin compared to their Caucasian
counterparts.15
In this issue of JAPI, Lele and Joshi16 report on
interesting new information on the relation of
adipocytokines with diabetes in urban western Indians.
They show that adiponectin and leptin have a reciprocal
association with diabetes. In a south Indian population,
we showed  that low adiponectin levels are associated
with hypertriglyceridemia, low HDL cholesterol, insulin
resistance and other components of the metabolic
syndrome.17 As low levels of adiponectin have been
demonstrated in migrant Indians, one could speculate
that this could be one of the mechanisms for the increased
diabetic tendency observed in Indians. It is of interest
that in the study by Lele and Joshi,16 leptin had a positive
association with obesity indices but a negative
association with diabetes. This has been earlier
documented in Caucasians.18 It is possible that
adipocytokines secreted from different fat depots may
have differential effects on diabetes.
Another interesting observation in the study
conducted by Lele and Joshi16 is that proinsulin showed
a positive association with diabetes and an inverse
association with adiponectin. It is well known that
compensatory hyperinsulinemia observed in pre-
diabetic stage is followed by decreased insulin secretion.
Indeed, at the time of clinical diagnosis of type 2 diabetes,
only 50% of the beta cell function is present.19 In this
regard, the link between adiponectin and beta cell
dysfunction shown in this study adds a new dimension
to the pathophysiology of diabetes in Indians.
Recent studies have shown increased levels of
inflammatory markers like C-reactive protein in Indians
compared to Caucasians.20 It was also shown that in
south Indians inflammatory markers are linked to
diabetes and this link is probably mediated through body
fat.21 Though hsCRP, an inflammatory predictor for
diabetes is associated with diabetes, TNF-α  failed to
show an association with diabetes in the study by Lele
and Joshi.16 The Asian Indian Phenotype could perhaps
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The prevalence of diabetes in India is growing rapidlyand recent studies have documented a 72% increase
in the prevalence of diabetes in urban areas in the last 15
years.1 Indeed, the number of subjects with diabetes in
India is expected to double from the current figures of
about 40 million to nearly 80 million by 2030.2 Increased
ethnic susceptibility to diabetes in Indians was identified
decades ago when migrant Indian studies showed
higher prevalence rates in diabetes compared to virtually
every other ethnic group studied.3  It was further shown
that Indians have evidence of hyperinsulinemia and
greater degree of insulin resistance compared to their
European counterparts.4-6 Later studies showed some
unique phenotypic features among Indians. While the
overall prevalence of obesity was lower, Indians tend to
have increased waist circumference compared to other
ethnic groups.7  This was attributed to increased visceral
fat.8 Even more interestingly, these features appear to be
present from birth as Indian neonates tend to have
increased body fat compared to their white Caucasian
counterparts despite lower birth weights.9  These unique
features led to the coining of the term ‘Asian Indian
Phenotype’.10
It has been recently recognized that adipose tissue is
not a mere depot for fat storage but is an active endocrine
organ. Adipose tissue secretes various adipocytokines
which includes adiponectin, leptin and resistin. These
cytokines have been linked to metabolic abnormalities
such as diabetes, dyslipidemia and insulin resistance
all of which predispose to coronary artery disease.11 Most
of these adipocytokines (e.g. resistin, visfatin and TNF-
α) increase the risk for diabetes, while adiponectin is
unique because it is known to be protective against
diabetes. Adiponectin has many metabolic functions
including regulation of energy homeostasis, decreasing
plasma glucose, inceasing clearence of glucose load, and
decreasing insulin resistance.11 With regard to resistin,
there have been contradictory findings with recent
studies suggesting it may be important in mice but not
in humans.12  Leptin plays a key role in the regulation of
body weight as it links the adipose tissue to the central
nervous system for the control of appetite and energy
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be expanded further to include decreased adiponectin
and increased hsCRP as possible additional components
of this phenotype seen in Indians.
India is currently experiencing an increasing obesity
epidemic. This is in contrast to the 1990’s where the
National Nutrition Monitoring Bureau documented the
prevalence of obesity in Indian women to be 4.1%22 and
the National Family Health Survey (NFHS) reported
obesity prevalence rates ranging between 3.5% to 4.1%.23
Today, over 20% of men and 30% of women in urban
areas have generalized obesity and nearly 40% of females
have abdominal obesity.24 It is further predicted that the
prevalence of obesity in India would further increase by
89% in males and 82% in females between 2002 and
2010.25
As India is presently facing a double threat due to the
obesity and diabetes epidemics, urgent measures are
necessary  to tackle the twin epidemics. Though both
these diseases have a strong genetic background, lifestyle
modification with increased physical activity, healthy
eating habits and modest weight loss has been shown to
prevent diabetes in several studies. However, the
applicability and feasibility of these studies to the
community at large needs to be studied. National policies
need to be formulated to tackle the twin epidemics of
diabetes and obesity before they grow out of hand.
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